237 reports of this reaction
2.3% of all ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE reports
#8 most reported adverse reaction
HEADACHE is the #8 most commonly reported adverse reaction for ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE, manufactured by Kenvue Brands LLC. There are 237 FDA adverse event reports linking ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE to HEADACHE. This represents approximately 2.3% of all 10,191 adverse event reports for this drug.
Patients taking ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE who experience headache should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
HEADACHE is a less commonly reported adverse event for ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE, but still significant enough to appear in the safety profile.
In addition to headache, the following adverse reactions have been reported for ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE:
The following drugs have also been linked to headache in FDA adverse event reports:
HEADACHE has been reported as an adverse event in 237 FDA reports for ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
HEADACHE accounts for approximately 2.3% of all adverse event reports for ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE, making it a notable side effect.
If you experience headache while taking ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.